Publications
119
Citations
5,234
Est. group size
~7
Recurring co-author estimate
Active years
34
Publishing since 1992
This researcher works in oncology, with a focus on genitourinary cancers such as bladder, kidney, and prostate cancer, including clinical trials of new immune-based drugs and genomic profiling of tumors to guide treatment decisions. The work spans early-phase drug trials, large population-based outcome studies (including studies of U.S. veterans), and some engineered immune-cell (CAR-T) cancer therapy research. Collaborations also touch on related areas like breast cancer, vascular disease, and cancer immunotherapy biomarkers.
Publication output has fluctuated over the past decade with peaks in 2019, 2020, and especially 2025, and a dip in 2024, suggesting variable but generally active and possibly increasing recent output.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Systemic immune response induced by radiofrequency ablation versus microwave ablation at varying powers in murine models of hepatocellular carcinoma
Translational Cancer Research · 2025
- Does Manual Acupuncture Improve Gastroesophageal Reflux Disease Symptoms? A Trial Sequential Meta-Analysis
Complementary Medicine Research · 2025
- Incorporating Structured and Unstructured Data Sources to Identify and Characterize Hereditary Cancer Testing Among Veterans With Metastatic Castration-Resistant Prostate Cancer
JCO Clinical Cancer Informatics · 2025
- Progression of Carotid Stenosis Among U.S. Veterans
Journal of Vascular Surgery · 2025
- Abdominal Aortic Aneurysm Epidemiology in United States Veterans in the Current Era
Journal of Vascular Surgery · 2025
- Abstract PO1-20-06: Phase 2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate (ISAC) BDC-1001 +/- pertuzumab in patients with HER2-positive metastatic breast cancer (MBC) previously treated with trastuzumab deruxtecan
Cancer Research · 2024
- Editorial: Innovative molecular therapeutic approaches in urothelial carcinoma
Frontiers in Oncology · 2024
- Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma
JAMA Oncology · 2023
- Functional Brain Network Alterations in Patients With Systemic Lupus Erythematosus With Different Cognitive Function States: A Graph Theory Analysis Study
Journal of Computer Assisted Tomography · 2023
- 657MO Recommended phase II dose (RP2D) selection and pharmacodynamic (PD) data of the first-in-human immune-stimulating antibody conjugate (ISAC) BDC-1001 in patients (pts) with advanced HER2-expressing solid tumors
Annals of Oncology · 2023
- A phase 1/2 study of a first-in-human immune-stimulating antibody conjugate (ISAC) BDC-1001 in patients with advanced HER2-expressing solid tumors.
Journal of Clinical Oncology · 2023
- 716 Phase 2 study of the HER2-targeting TLR7/8 immune stimulating antibody conjugate (ISAC) BDC-1001 monotherapy +/- nivolumab in patients with HER2+ colorectal, endometrial, or gastroesophageal cancer
Regular and Young Investigator Award Abstracts · 2023
- Deoxyribonucleic Acid Damage Response Defects
Advances in Oncology · 2022
- Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma
European Urology Focus · 2020
- Impact of lack of surgery on outcomes in elderly women with nonmetastatic breast cancer—A surveillance, epidemiology, and end results 18 population based study
Medicine · 2020
- Journal of Clinical Oncology×14
- Cancer Medicine×4
- Annals of Oncology×4
- Oncotarget×3
- Frontiers in Oncology×3
- Amir Mortazavi
Medicine · The Ohio State University
- Shang-Jui Wang
Medicine · The Ohio State University
- Daniel Sidhom
Medicine · Indiana University
- Debra L. Zynger
Medicine · The Ohio State University
- Shawn Dason
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile